Arcbest Corp /Tx/
ARCB Nasdaq Trucking (No Local) Financials FY2016βFY2025
What Arcbest Corp /Tx/ does
No business description yet.
- Legal name
- ARCBEST CORP /TX/
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001104659-26-019699
0000894405
Revenue and margins
Arcbest Corp /Tx/ had $4.0B of revenue in fiscal 2025, down 4.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $114M in fiscal 2025, 2.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Arcbest Corp /Tx/ returned $86.5M to shareholders in fiscal 2025, 76% of free cash flow. The diluted share count fell 3.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Arcbest Corp /Tx/ can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $125M | $326M | $330M | $157M | $124M |
| Debt incl. finance leases | $226M | $265M | $229M | $189M | $224M |
| Net debt / EBITDA | 0.3x | β0.1x | β0.3x | 0.1x | 0.4x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.1x | 0.2x |
| Current ratio | 1.1x | 1.3x | 1.3x | 1.0x | 1.0x |
| Quick ratio | 1.1x | 1.3x | 1.3x | 1.0x | 1.0x |
| Total assets | $2.1B | $2.5B | $2.5B | $2.4B | $2.5B |
| Total liabilities | $1.2B | $1.3B | $1.2B | $1.1B | $1.2B |
| Shareholders' equity | $929M | $1.2B | $1.2B | $1.3B | $1.3B |
| Net debt (β = net cash) | $101M | β$61.3M | β$101M | $31.9M | $99.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 5 / 8 | 5 / 8 | 7 / 8 | 6 / 8 | 8 / 8 | 5 / 8 | 5 / 8 | 4 / 8 |
| Accruals ratio | β7.3% | β7.0% | β12.9% | β8.2% | β7.9% | β5.7% | β7.5% | β5.1% | β4.6% | β6.9% |
| Altman Z'' | 2.57 | 2.88 | 3.30 | 3.09 | 3.31 | 3.17 | 3.97 | 3.67 | 3.87 | 3.31 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.7B | $2.8B | $3.1B | $3.0B | $2.9B | $3.8B | $5.0B | $4.4B | $4.2B | $4.0B |
| Research and development | β | β | β | β | $25.6M | $32.8M | $40.8M | $52.4M | $34.1M | $29.1M |
| Operating income | $34.1M | $61.3M | $109M | $63.8M | $98.3M | $277M | $395M | $173M | $244M | $90.3M |
| Pretax income | $28.3M | $51.6M | $84.4M | $51.5M | $92.5M | $273M | $388M | $187M | $219M | $83.1M |
| Income tax | $9.6M | β$8.2M | $17.1M | $11.5M | $21.4M | $62.6M | $93.7M | $44.8M | $45.4M | $23.0M |
| Net income | $18.7M | $59.7M | $67.3M | $40.0M | $71.1M | $214M | $298M | $195M | $174M | $60.1M |
| Net income to common | $18.5M | $59.5M | $67.1M | $40.0M | $71.1M | $214M | $298M | $195M | $174M | $60.1M |
| Diluted EPS | $0.71 | $2.25 | $2.51 | $1.51 | $2.69 | $7.98 | $11.69 | $7.93 | $7.30 | $2.62 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $112M | $152M | $255M | $170M | $206M | $324M | $471M | $322M | $286M | $229M |
| Capital expenditure | $68.3M | $65.8M | $44.0M | $91.0M | $43.2M | $58.4M | $148M | $219M | $223M | $115M |
| Free cash flow | $43.7M | $86.1M | $211M | $79.4M | $163M | $265M | $323M | $103M | $62.7M | $114M |
| Depreciation and amortization | $103M | $103M | $109M | $112M | $118M | $123M | $138M | $145M | $149M | $170M |
| Stock-based compensation | $7.6M | $7.0M | $8.4M | $9.5M | $10.5M | $11.4M | $12.8M | $11.4M | $11.4M | $10.6M |
| Acquisitions | $24.8M | β | β | β | β | $239M | β$2.3M | β | β | β |
| Share buybacks | $9.5M | $6.0M | $9.4M | $9.1M | $6.6M | $83.1M | $65.0M | $91.5M | $75.2M | $75.6M |
| Dividends paid | $8.3M | $8.3M | $8.2M | $8.2M | $8.2M | $8.1M | $10.8M | $11.5M | $11.3M | $11.0M |
| Dividends and buybacks | $17.8M | $14.3M | $17.6M | $17.3M | $14.8M | $91.2M | $75.8M | $103M | $86.5M | $86.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $171M | $177M | $297M | $318M | $369M | $125M | $326M | $330M | $157M | $124M |
| Total debt | $244M | $269M | $292M | $324M | $284M | $226M | $265M | $229M | $189M | $224M |
| Current assets | $491M | $522M | $649M | $664M | $758M | $776M | $990M | $885M | $676M | $626M |
| Current liabilities | $396M | $403M | $451M | $444M | $507M | $703M | $768M | $702M | $666M | $657M |
| Property and equipment, net | $533M | $591M | $631M | $684M | $679M | $696M | $800M | $915M | $1.1B | $1.1B |
| Goodwill | $109M | $108M | $108M | $88.3M | $88.3M | $300M | $305M | $305M | $305M | $305M |
| Intangible assets | $80.5M | $73.5M | $68.9M | $58.8M | $55.0M | $127M | $114M | $101M | $88.6M | $69.4M |
| Total assets | $1.3B | $1.4B | $1.5B | $1.7B | $1.8B | $2.1B | $2.5B | $2.5B | $2.4B | $2.5B |
| Total liabilities | $683M | $714M | $822M | $888M | $950M | $1.2B | $1.3B | $1.2B | $1.1B | $1.2B |
| Shareholders' equity | $599M | $651M | $718M | $763M | $829M | $929M | $1.2B | $1.2B | $1.3B | $1.3B |
| Margins | ||||||||||
| Operating margin | 1.3% | 2.2% | 3.5% | 2.1% | 3.3% | 7.4% | 7.8% | 3.9% | 5.8% | 2.3% |
| EBITDA margin | 5.1% | 5.8% | 7.0% | 5.9% | 7.4% | 10.6% | 10.6% | 7.2% | 9.4% | 6.5% |
| Net margin | 0.7% | 2.1% | 2.2% | 1.3% | 2.4% | 5.7% | 5.9% | 4.4% | 4.2% | 1.5% |
| FCF margin | 1.6% | 3.0% | 6.8% | 2.7% | 5.5% | 7.0% | 6.4% | 2.3% | 1.5% | 2.8% |
| Returns | ||||||||||
| Return on capital | 3.3% | 8.3% | 12.2% | 6.4% | 10.2% | 20.7% | 27.5% | 11.5% | 14.4% | 4.7% |
| Return on capital employed | 3.8% | 6.4% | 10.0% | 5.3% | 7.7% | 19.6% | 22.9% | 9.7% | 13.9% | 5.0% |
| Return on equity | 3.1% | 9.6% | 9.8% | 5.4% | 8.9% | 24.3% | 28.7% | 16.3% | 13.6% | 4.6% |
| Return on assets | 1.5% | 4.5% | 4.6% | 2.5% | 4.1% | 11.0% | 12.9% | 7.8% | 7.1% | 2.5% |
| Return on tangible equity | 4.5% | 12.7% | 12.4% | 6.5% | 10.4% | 42.5% | 40.7% | 23.4% | 18.9% | 6.5% |
| Growth | ||||||||||
| Revenue growth | β | 4.7% | 9.5% | β3.4% | β1.6% | 28.1% | 33.5% | β12.0% | β5.6% | β4.0% |
| Net income growth | β | 220.2% | 12.6% | β40.6% | 77.8% | 200.3% | 39.7% | β34.5% | β11.0% | β65.5% |
| EPS growth | β | 216.9% | 11.6% | β39.8% | 78.1% | 196.7% | 46.5% | β32.2% | β7.9% | β64.1% |
| FCF growth | β | 97.2% | 145.4% | β62.4% | 104.9% | 62.9% | 21.7% | β68.0% | β39.2% | 82.0% |
| Share count change | β | 0.6% | 1.0% | β0.9% | β0.1% | 1.3% | β4.7% | β3.4% | β3.3% | β3.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.5x | 0.6x | β0.0x | 0.0x | β0.4x | 0.3x | β0.1x | β0.3x | 0.1x | 0.4x |
| Debt / equity | 0.4x | 0.4x | 0.4x | 0.4x | 0.3x | 0.2x | 0.2x | 0.2x | 0.1x | 0.2x |
| Current ratio | 1.2x | 1.3x | 1.4x | 1.5x | 1.5x | 1.1x | 1.3x | 1.3x | 1.0x | 1.0x |
| Quick ratio | 1.2x | 1.3x | 1.4x | 1.5x | 1.5x | 1.1x | 1.3x | 1.3x | 1.0x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 2.3% | 1.4% | 3.0% | 1.5% | 1.6% | 2.9% | 4.9% | 5.3% | 2.9% |
| Stock comp / revenue | 0.3% | 0.2% | 0.3% | 0.3% | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Payouts / FCF | 40.8% | 16.6% | 8.3% | 21.8% | 9.1% | 34.4% | 23.5% | 99.9% | 137.9% | 75.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 5.0 | 5.0 | 7.0 | 6.0 | 8.0 | 5.0 | 5.0 | 4.0 |
| Altman Z'' | 2.6 | 2.9 | 3.3 | 3.1 | 3.3 | 3.2 | 4.0 | 3.7 | 3.9 | 3.3 |
| Accruals ratio | β7.3% | β7.0% | β12.9% | β8.2% | β7.9% | β5.7% | β7.5% | β5.1% | β4.6% | β6.9% |
Source: SEC EDGAR XBRL filings (CIK 0000894405). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.